nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—MARK2—salivary gland cancer	0.307	0.428	CbGaD
Sunitinib—DAPK1—salivary gland cancer	0.213	0.297	CbGaD
Sunitinib—MAP2K2—salivary gland cancer	0.198	0.276	CbGaD
Sunitinib—RPS6KB1—neck—salivary gland cancer	0.000445	0.00446	CbGeAlD
Sunitinib—BRD4—lymphoid tissue—salivary gland cancer	0.000444	0.00445	CbGeAlD
Sunitinib—STK11—lymphoid tissue—salivary gland cancer	0.000444	0.00445	CbGeAlD
Sunitinib—RPS6KA3—parotid gland—salivary gland cancer	0.000443	0.00444	CbGeAlD
Sunitinib—RET—neck—salivary gland cancer	0.000442	0.00443	CbGeAlD
Sunitinib—CSNK1A1—parotid gland—salivary gland cancer	0.000434	0.00435	CbGeAlD
Sunitinib—NUAK2—saliva-secreting gland—salivary gland cancer	0.000433	0.00434	CbGeAlD
Sunitinib—GRK4—lymph node—salivary gland cancer	0.000431	0.00433	CbGeAlD
Sunitinib—CLK1—parotid gland—salivary gland cancer	0.000431	0.00433	CbGeAlD
Sunitinib—ROCK1—connective tissue—salivary gland cancer	0.000429	0.0043	CbGeAlD
Sunitinib—RPS6KA3—saliva-secreting gland—salivary gland cancer	0.000424	0.00425	CbGeAlD
Sunitinib—FGFR2—neck—salivary gland cancer	0.00042	0.00421	CbGeAlD
Sunitinib—CSNK1A1—saliva-secreting gland—salivary gland cancer	0.000416	0.00417	CbGeAlD
Sunitinib—CLK1—saliva-secreting gland—salivary gland cancer	0.000413	0.00414	CbGeAlD
Sunitinib—ROCK1—epithelium—salivary gland cancer	0.000407	0.00408	CbGeAlD
Sunitinib—SNRK—lymphoid tissue—salivary gland cancer	0.000405	0.00406	CbGeAlD
Sunitinib—INSR—lymphoid tissue—salivary gland cancer	0.000405	0.00406	CbGeAlD
Sunitinib—CSNK1E—parotid gland—salivary gland cancer	0.000402	0.00403	CbGeAlD
Sunitinib—MAP4K4—connective tissue—salivary gland cancer	0.000401	0.00402	CbGeAlD
Sunitinib—STK38—lymphoid tissue—salivary gland cancer	0.000398	0.004	CbGeAlD
Sunitinib—RPS6KA2—lymphoid tissue—salivary gland cancer	0.000398	0.004	CbGeAlD
Sunitinib—IRAK4—parotid gland—salivary gland cancer	0.000396	0.00397	CbGeAlD
Sunitinib—FLT3—connective tissue—salivary gland cancer	0.000395	0.00396	CbGeAlD
Sunitinib—PKN1—lymphoid tissue—salivary gland cancer	0.000392	0.00394	CbGeAlD
Sunitinib—CSNK1G2—lymphoid tissue—salivary gland cancer	0.000392	0.00394	CbGeAlD
Sunitinib—RPS6KA3—connective tissue—salivary gland cancer	0.00039	0.00391	CbGeAlD
Sunitinib—FLT1—neck—salivary gland cancer	0.000389	0.0039	CbGeAlD
Sunitinib—ULK3—parotid gland—salivary gland cancer	0.000387	0.00388	CbGeAlD
Sunitinib—MAP2K1—connective tissue—salivary gland cancer	0.000387	0.00388	CbGeAlD
Sunitinib—PRPF4—lymphoid tissue—salivary gland cancer	0.000387	0.00388	CbGeAlD
Sunitinib—CSNK1E—saliva-secreting gland—salivary gland cancer	0.000385	0.00386	CbGeAlD
Sunitinib—PRPF4B—lymphoid tissue—salivary gland cancer	0.000381	0.00382	CbGeAlD
Sunitinib—MAP3K7—parotid gland—salivary gland cancer	0.000381	0.00382	CbGeAlD
Sunitinib—CLK1—connective tissue—salivary gland cancer	0.00038	0.00381	CbGeAlD
Sunitinib—IRAK4—saliva-secreting gland—salivary gland cancer	0.000379	0.0038	CbGeAlD
Sunitinib—TBK1—parotid gland—salivary gland cancer	0.000376	0.00378	CbGeAlD
Sunitinib—TYK2—parotid gland—salivary gland cancer	0.000374	0.00375	CbGeAlD
Sunitinib—BMP2K—connective tissue—salivary gland cancer	0.000373	0.00374	CbGeAlD
Sunitinib—MAP2K2—saliva-secreting gland—salivary gland cancer	0.000371	0.00372	CbGeAlD
Sunitinib—ULK3—saliva-secreting gland—salivary gland cancer	0.000371	0.00372	CbGeAlD
Sunitinib—MAP2K1—epithelium—salivary gland cancer	0.000367	0.00369	CbGeAlD
Sunitinib—MYLK—lymphoid tissue—salivary gland cancer	0.000366	0.00367	CbGeAlD
Sunitinib—MAP3K7—saliva-secreting gland—salivary gland cancer	0.000365	0.00366	CbGeAlD
Sunitinib—PRKAA1—connective tissue—salivary gland cancer	0.000364	0.00365	CbGeAlD
Sunitinib—RPS6KB1—parotid gland—salivary gland cancer	0.000362	0.00363	CbGeAlD
Sunitinib—PLK4—lymphoid tissue—salivary gland cancer	0.000362	0.00363	CbGeAlD
Sunitinib—TBK1—saliva-secreting gland—salivary gland cancer	0.000361	0.00362	CbGeAlD
Sunitinib—PTK2B—connective tissue—salivary gland cancer	0.00036	0.00361	CbGeAlD
Sunitinib—STK4—lymphoid tissue—salivary gland cancer	0.000359	0.0036	CbGeAlD
Sunitinib—TYK2—saliva-secreting gland—salivary gland cancer	0.000358	0.00359	CbGeAlD
Sunitinib—RPS6KB1—saliva-secreting gland—salivary gland cancer	0.000347	0.00348	CbGeAlD
Sunitinib—SLK—parotid gland—salivary gland cancer	0.000345	0.00346	CbGeAlD
Sunitinib—STK16—lymphoid tissue—salivary gland cancer	0.000341	0.00343	CbGeAlD
Sunitinib—FLT4—epithelium—salivary gland cancer	0.000341	0.00342	CbGeAlD
Sunitinib—HIPK2—lymphoid tissue—salivary gland cancer	0.00034	0.00341	CbGeAlD
Sunitinib—TYRO3—lymphoid tissue—salivary gland cancer	0.00034	0.00341	CbGeAlD
Sunitinib—ALK—lymphoid tissue—salivary gland cancer	0.00034	0.00341	CbGeAlD
Sunitinib—MAP3K2—connective tissue—salivary gland cancer	0.000338	0.00339	CbGeAlD
Sunitinib—MAP4K1—lymphoid tissue—salivary gland cancer	0.000333	0.00334	CbGeAlD
Sunitinib—SLK—saliva-secreting gland—salivary gland cancer	0.00033	0.00331	CbGeAlD
Sunitinib—TYK2—connective tissue—salivary gland cancer	0.000329	0.0033	CbGeAlD
Sunitinib—KDR—neck—salivary gland cancer	0.000329	0.0033	CbGeAlD
Sunitinib—MAP3K3—parotid gland—salivary gland cancer	0.000328	0.00329	CbGeAlD
Sunitinib—MAP4K5—parotid gland—salivary gland cancer	0.000328	0.00329	CbGeAlD
Sunitinib—FGFR2—saliva-secreting gland—salivary gland cancer	0.000328	0.00329	CbGeAlD
Sunitinib—PRKAA2—lymph node—salivary gland cancer	0.000327	0.00328	CbGeAlD
Sunitinib—CLK2—lymphoid tissue—salivary gland cancer	0.000323	0.00324	CbGeAlD
Sunitinib—MAP4K2—lymphoid tissue—salivary gland cancer	0.000322	0.00323	CbGeAlD
Sunitinib—RPS6KB1—connective tissue—salivary gland cancer	0.000319	0.0032	CbGeAlD
Sunitinib—FLT1—parotid gland—salivary gland cancer	0.000317	0.00318	CbGeAlD
Sunitinib—RET—connective tissue—salivary gland cancer	0.000317	0.00318	CbGeAlD
Sunitinib—AXL—connective tissue—salivary gland cancer	0.000315	0.00316	CbGeAlD
Sunitinib—STK17B—lymph node—salivary gland cancer	0.000315	0.00316	CbGeAlD
Sunitinib—MAP4K5—saliva-secreting gland—salivary gland cancer	0.000314	0.00315	CbGeAlD
Sunitinib—MAP3K3—saliva-secreting gland—salivary gland cancer	0.000314	0.00315	CbGeAlD
Sunitinib—ROCK1—lymphoid tissue—salivary gland cancer	0.000313	0.00314	CbGeAlD
Sunitinib—EPHB6—parotid gland—salivary gland cancer	0.000313	0.00314	CbGeAlD
Sunitinib—DYRK1A—lymphoid tissue—salivary gland cancer	0.000306	0.00307	CbGeAlD
Sunitinib—FLT1—saliva-secreting gland—salivary gland cancer	0.000304	0.00305	CbGeAlD
Sunitinib—YES1—parotid gland—salivary gland cancer	0.000303	0.00304	CbGeAlD
Sunitinib—RPS6KB1—epithelium—salivary gland cancer	0.000303	0.00303	CbGeAlD
Sunitinib—FGFR2—connective tissue—salivary gland cancer	0.000301	0.00302	CbGeAlD
Sunitinib—RET—epithelium—salivary gland cancer	0.000301	0.00302	CbGeAlD
Sunitinib—EPHB6—saliva-secreting gland—salivary gland cancer	0.0003	0.00301	CbGeAlD
Sunitinib—JAK2—connective tissue—salivary gland cancer	0.000299	0.003	CbGeAlD
Sunitinib—TAOK3—parotid gland—salivary gland cancer	0.000299	0.003	CbGeAlD
Sunitinib—MERTK—lymphoid tissue—salivary gland cancer	0.000298	0.00299	CbGeAlD
Sunitinib—FYN—connective tissue—salivary gland cancer	0.000295	0.00296	CbGeAlD
Sunitinib—MAP4K4—lymphoid tissue—salivary gland cancer	0.000293	0.00294	CbGeAlD
Sunitinib—KIT—neck—salivary gland cancer	0.000292	0.00292	CbGeAlD
Sunitinib—YES1—saliva-secreting gland—salivary gland cancer	0.00029	0.00291	CbGeAlD
Sunitinib—STK17A—lymph node—salivary gland cancer	0.00029	0.00291	CbGeAlD
Sunitinib—FLT3—lymphoid tissue—salivary gland cancer	0.000289	0.0029	CbGeAlD
Sunitinib—TAOK3—saliva-secreting gland—salivary gland cancer	0.000286	0.00287	CbGeAlD
Sunitinib—CDK14—lymph node—salivary gland cancer	0.000286	0.00287	CbGeAlD
Sunitinib—FGFR2—epithelium—salivary gland cancer	0.000286	0.00287	CbGeAlD
Sunitinib—RPS6KA3—lymphoid tissue—salivary gland cancer	0.000285	0.00286	CbGeAlD
Sunitinib—PDGFRB—neck—salivary gland cancer	0.000285	0.00286	CbGeAlD
Sunitinib—JAK2—epithelium—salivary gland cancer	0.000284	0.00285	CbGeAlD
Sunitinib—MAP2K1—lymphoid tissue—salivary gland cancer	0.000283	0.00284	CbGeAlD
Sunitinib—PAK3—lymph node—salivary gland cancer	0.000282	0.00283	CbGeAlD
Sunitinib—CDK16—lymph node—salivary gland cancer	0.000282	0.00283	CbGeAlD
Sunitinib—LATS2—lymph node—salivary gland cancer	0.000282	0.00283	CbGeAlD
Sunitinib—CSNK1A1—lymphoid tissue—salivary gland cancer	0.000279	0.0028	CbGeAlD
Sunitinib—FLT1—connective tissue—salivary gland cancer	0.000279	0.0028	CbGeAlD
Sunitinib—RPS6KA5—lymph node—salivary gland cancer	0.000278	0.00279	CbGeAlD
Sunitinib—CLK1—lymphoid tissue—salivary gland cancer	0.000277	0.00278	CbGeAlD
Sunitinib—KDR—parotid gland—salivary gland cancer	0.000268	0.00269	CbGeAlD
Sunitinib—MAP2K5—parotid gland—salivary gland cancer	0.000268	0.00269	CbGeAlD
Sunitinib—CLK4—lymph node—salivary gland cancer	0.000268	0.00268	CbGeAlD
Sunitinib—YES1—connective tissue—salivary gland cancer	0.000266	0.00267	CbGeAlD
Sunitinib—PRKAA1—lymphoid tissue—salivary gland cancer	0.000266	0.00267	CbGeAlD
Sunitinib—FLT1—epithelium—salivary gland cancer	0.000265	0.00266	CbGeAlD
Sunitinib—ITK—lymph node—salivary gland cancer	0.000264	0.00265	CbGeAlD
Sunitinib—SBK1—lymph node—salivary gland cancer	0.000264	0.00265	CbGeAlD
Sunitinib—PTK2B—lymphoid tissue—salivary gland cancer	0.000263	0.00264	CbGeAlD
Sunitinib—TAOK3—connective tissue—salivary gland cancer	0.000263	0.00264	CbGeAlD
Sunitinib—FLT4—lymphoid tissue—salivary gland cancer	0.000262	0.00263	CbGeAlD
Sunitinib—PDGFRA—connective tissue—salivary gland cancer	0.000261	0.00262	CbGeAlD
Sunitinib—BLK—lymph node—salivary gland cancer	0.000261	0.00262	CbGeAlD
Sunitinib—DAPK1—lymph node—salivary gland cancer	0.000258	0.00259	CbGeAlD
Sunitinib—PHKG1—lymph node—salivary gland cancer	0.000258	0.00259	CbGeAlD
Sunitinib—KDR—saliva-secreting gland—salivary gland cancer	0.000257	0.00257	CbGeAlD
Sunitinib—MAP2K5—saliva-secreting gland—salivary gland cancer	0.000257	0.00257	CbGeAlD
Sunitinib—IRAK4—lymphoid tissue—salivary gland cancer	0.000255	0.00256	CbGeAlD
Sunitinib—BRD4—lymph node—salivary gland cancer	0.00025	0.00251	CbGeAlD
Sunitinib—STK11—lymph node—salivary gland cancer	0.00025	0.00251	CbGeAlD
Sunitinib—MAP2K2—lymphoid tissue—salivary gland cancer	0.000249	0.0025	CbGeAlD
Sunitinib—RIOK1—lymph node—salivary gland cancer	0.000248	0.00249	CbGeAlD
Sunitinib—RPS6KA1—lymph node—salivary gland cancer	0.000248	0.00249	CbGeAlD
Sunitinib—MAP3K2—lymphoid tissue—salivary gland cancer	0.000247	0.00248	CbGeAlD
Sunitinib—TNIK—lymph node—salivary gland cancer	0.000243	0.00244	CbGeAlD
Sunitinib—MARK2—lymph node—salivary gland cancer	0.000243	0.00244	CbGeAlD
Sunitinib—TBK1—lymphoid tissue—salivary gland cancer	0.000242	0.00243	CbGeAlD
Sunitinib—SGK3—lymph node—salivary gland cancer	0.000241	0.00241	CbGeAlD
Sunitinib—TYK2—lymphoid tissue—salivary gland cancer	0.000241	0.00241	CbGeAlD
Sunitinib—ICK—lymph node—salivary gland cancer	0.000238	0.00239	CbGeAlD
Sunitinib—KIT—parotid gland—salivary gland cancer	0.000237	0.00238	CbGeAlD
Sunitinib—KDR—connective tissue—salivary gland cancer	0.000236	0.00237	CbGeAlD
Sunitinib—RPS6KB1—lymphoid tissue—salivary gland cancer	0.000233	0.00234	CbGeAlD
Sunitinib—PDGFRB—parotid gland—salivary gland cancer	0.000232	0.00233	CbGeAlD
Sunitinib—FGR—lymphoid tissue—salivary gland cancer	0.000232	0.00232	CbGeAlD
Sunitinib—RET—lymphoid tissue—salivary gland cancer	0.000232	0.00232	CbGeAlD
Sunitinib—AXL—lymphoid tissue—salivary gland cancer	0.000231	0.00231	CbGeAlD
Sunitinib—CHEK2—lymph node—salivary gland cancer	0.00023	0.00231	CbGeAlD
Sunitinib—NUAK1—lymph node—salivary gland cancer	0.00023	0.00231	CbGeAlD
Sunitinib—CSF1R—connective tissue—salivary gland cancer	0.00023	0.00231	CbGeAlD
Sunitinib—SNRK—lymph node—salivary gland cancer	0.000228	0.00229	CbGeAlD
Sunitinib—OXSR1—lymph node—salivary gland cancer	0.000228	0.00229	CbGeAlD
Sunitinib—INSR—lymph node—salivary gland cancer	0.000228	0.00229	CbGeAlD
Sunitinib—KIT—saliva-secreting gland—salivary gland cancer	0.000227	0.00228	CbGeAlD
Sunitinib—STK38—lymph node—salivary gland cancer	0.000225	0.00225	CbGeAlD
Sunitinib—RPS6KA2—lymph node—salivary gland cancer	0.000225	0.00225	CbGeAlD
Sunitinib—KDR—epithelium—salivary gland cancer	0.000224	0.00225	CbGeAlD
Sunitinib—AURKC—lymph node—salivary gland cancer	0.000223	0.00224	CbGeAlD
Sunitinib—PDGFRB—saliva-secreting gland—salivary gland cancer	0.000222	0.00223	CbGeAlD
Sunitinib—PKN1—lymph node—salivary gland cancer	0.000221	0.00222	CbGeAlD
Sunitinib—CSNK1G2—lymph node—salivary gland cancer	0.000221	0.00222	CbGeAlD
Sunitinib—JAK2—lymphoid tissue—salivary gland cancer	0.000219	0.0022	CbGeAlD
Sunitinib—PRPF4—lymph node—salivary gland cancer	0.000218	0.00219	CbGeAlD
Sunitinib—FYN—lymphoid tissue—salivary gland cancer	0.000216	0.00217	CbGeAlD
Sunitinib—PRPF4B—lymph node—salivary gland cancer	0.000215	0.00216	CbGeAlD
Sunitinib—STK39—lymph node—salivary gland cancer	0.000212	0.00213	CbGeAlD
Sunitinib—MAP4K5—lymphoid tissue—salivary gland cancer	0.000211	0.00212	CbGeAlD
Sunitinib—CSNK2A1—lymph node—salivary gland cancer	0.000209	0.0021	CbGeAlD
Sunitinib—KIT—connective tissue—salivary gland cancer	0.000209	0.0021	CbGeAlD
Sunitinib—MYLK—lymph node—salivary gland cancer	0.000207	0.00207	CbGeAlD
Sunitinib—PDGFRB—connective tissue—salivary gland cancer	0.000204	0.00205	CbGeAlD
Sunitinib—PLK4—lymph node—salivary gland cancer	0.000204	0.00205	CbGeAlD
Sunitinib—FLT1—lymphoid tissue—salivary gland cancer	0.000204	0.00205	CbGeAlD
Sunitinib—STK4—lymph node—salivary gland cancer	0.000203	0.00203	CbGeAlD
Sunitinib—PHKG2—lymph node—salivary gland cancer	0.000199	0.002	CbGeAlD
Sunitinib—KIT—epithelium—salivary gland cancer	0.000198	0.00199	CbGeAlD
Sunitinib—STK24—lymph node—salivary gland cancer	0.000198	0.00199	CbGeAlD
Sunitinib—DAPK2—lymph node—salivary gland cancer	0.000196	0.00196	CbGeAlD
Sunitinib—YES1—lymphoid tissue—salivary gland cancer	0.000195	0.00195	CbGeAlD
Sunitinib—PDGFRB—epithelium—salivary gland cancer	0.000194	0.00194	CbGeAlD
Sunitinib—STK10—lymphoid tissue—salivary gland cancer	0.000193	0.00194	CbGeAlD
Sunitinib—STK16—lymph node—salivary gland cancer	0.000193	0.00193	CbGeAlD
Sunitinib—TAOK3—lymphoid tissue—salivary gland cancer	0.000192	0.00193	CbGeAlD
Sunitinib—HIPK2—lymph node—salivary gland cancer	0.000192	0.00192	CbGeAlD
Sunitinib—HIPK3—lymph node—salivary gland cancer	0.000192	0.00192	CbGeAlD
Sunitinib—ALK—lymph node—salivary gland cancer	0.000192	0.00192	CbGeAlD
Sunitinib—PDGFRA—lymphoid tissue—salivary gland cancer	0.000191	0.00192	CbGeAlD
Sunitinib—TNK1—lymph node—salivary gland cancer	0.00019	0.0019	CbGeAlD
Sunitinib—RIOK2—lymph node—salivary gland cancer	0.00019	0.0019	CbGeAlD
Sunitinib—MAP4K1—lymph node—salivary gland cancer	0.000188	0.00188	CbGeAlD
Sunitinib—DAPK3—lymph node—salivary gland cancer	0.000184	0.00185	CbGeAlD
Sunitinib—CLK2—lymph node—salivary gland cancer	0.000182	0.00183	CbGeAlD
Sunitinib—MAP4K2—lymph node—salivary gland cancer	0.000182	0.00182	CbGeAlD
Sunitinib—STK3—lymph node—salivary gland cancer	0.000179	0.0018	CbGeAlD
Sunitinib—KDR—lymphoid tissue—salivary gland cancer	0.000172	0.00173	CbGeAlD
Sunitinib—DYRK1A—lymph node—salivary gland cancer	0.000172	0.00173	CbGeAlD
Sunitinib—MERTK—lymph node—salivary gland cancer	0.000168	0.00169	CbGeAlD
Sunitinib—CSF1R—lymphoid tissue—salivary gland cancer	0.000168	0.00169	CbGeAlD
Sunitinib—MAP4K4—lymph node—salivary gland cancer	0.000165	0.00166	CbGeAlD
Sunitinib—NUAK2—lymph node—salivary gland cancer	0.000164	0.00165	CbGeAlD
Sunitinib—MAP3K12—lymph node—salivary gland cancer	0.000163	0.00163	CbGeAlD
Sunitinib—FLT3—lymph node—salivary gland cancer	0.000163	0.00163	CbGeAlD
Sunitinib—RPS6KA3—lymph node—salivary gland cancer	0.000161	0.00161	CbGeAlD
Sunitinib—MAP2K1—lymph node—salivary gland cancer	0.00016	0.0016	CbGeAlD
Sunitinib—CSNK1A1—lymph node—salivary gland cancer	0.000158	0.00158	CbGeAlD
Sunitinib—CLK1—lymph node—salivary gland cancer	0.000157	0.00157	CbGeAlD
Sunitinib—CAMK2G—lymph node—salivary gland cancer	0.000154	0.00154	CbGeAlD
Sunitinib—BMP2K—lymph node—salivary gland cancer	0.000154	0.00154	CbGeAlD
Sunitinib—KIT—lymphoid tissue—salivary gland cancer	0.000153	0.00153	CbGeAlD
Sunitinib—LRRK2—lymph node—salivary gland cancer	0.000152	0.00153	CbGeAlD
Sunitinib—PRKAA1—lymph node—salivary gland cancer	0.00015	0.00151	CbGeAlD
Sunitinib—PDGFRB—lymphoid tissue—salivary gland cancer	0.000149	0.0015	CbGeAlD
Sunitinib—PTK2B—lymph node—salivary gland cancer	0.000148	0.00149	CbGeAlD
Sunitinib—FLT4—lymph node—salivary gland cancer	0.000148	0.00148	CbGeAlD
Sunitinib—CSNK1E—lymph node—salivary gland cancer	0.000146	0.00146	CbGeAlD
Sunitinib—FGFR1—lymph node—salivary gland cancer	0.000146	0.00146	CbGeAlD
Sunitinib—IRAK4—lymph node—salivary gland cancer	0.000144	0.00144	CbGeAlD
Sunitinib—MAP2K2—lymph node—salivary gland cancer	0.000141	0.00141	CbGeAlD
Sunitinib—ULK3—lymph node—salivary gland cancer	0.000141	0.00141	CbGeAlD
Sunitinib—MAP3K2—lymph node—salivary gland cancer	0.00014	0.0014	CbGeAlD
Sunitinib—MAP3K7—lymph node—salivary gland cancer	0.000138	0.00139	CbGeAlD
Sunitinib—TBK1—lymph node—salivary gland cancer	0.000137	0.00137	CbGeAlD
Sunitinib—TYK2—lymph node—salivary gland cancer	0.000136	0.00136	CbGeAlD
Sunitinib—IRAK1—lymph node—salivary gland cancer	0.000134	0.00134	CbGeAlD
Sunitinib—RPS6KB1—lymph node—salivary gland cancer	0.000131	0.00132	CbGeAlD
Sunitinib—RET—lymph node—salivary gland cancer	0.000131	0.00131	CbGeAlD
Sunitinib—FGR—lymph node—salivary gland cancer	0.000131	0.00131	CbGeAlD
Sunitinib—ABCG2—parotid gland—salivary gland cancer	0.00013	0.00131	CbGeAlD
Sunitinib—AXL—lymph node—salivary gland cancer	0.00013	0.00131	CbGeAlD
Sunitinib—SLK—lymph node—salivary gland cancer	0.000125	0.00126	CbGeAlD
Sunitinib—ABCG2—saliva-secreting gland—salivary gland cancer	0.000125	0.00125	CbGeAlD
Sunitinib—JAK2—lymph node—salivary gland cancer	0.000124	0.00124	CbGeAlD
Sunitinib—FYN—lymph node—salivary gland cancer	0.000122	0.00122	CbGeAlD
Sunitinib—MAP4K5—lymph node—salivary gland cancer	0.000119	0.00119	CbGeAlD
Sunitinib—MAP3K3—lymph node—salivary gland cancer	0.000119	0.00119	CbGeAlD
Sunitinib—FLT1—lymph node—salivary gland cancer	0.000115	0.00115	CbGeAlD
Sunitinib—EPHB6—lymph node—salivary gland cancer	0.000114	0.00114	CbGeAlD
Sunitinib—YES1—lymph node—salivary gland cancer	0.00011	0.0011	CbGeAlD
Sunitinib—STK10—lymph node—salivary gland cancer	0.000109	0.00109	CbGeAlD
Sunitinib—TAOK3—lymph node—salivary gland cancer	0.000109	0.00109	CbGeAlD
Sunitinib—PDGFRA—lymph node—salivary gland cancer	0.000108	0.00108	CbGeAlD
Sunitinib—MAP2K5—lymph node—salivary gland cancer	9.73e-05	0.000976	CbGeAlD
Sunitinib—KDR—lymph node—salivary gland cancer	9.73e-05	0.000976	CbGeAlD
Sunitinib—CSF1R—lymph node—salivary gland cancer	9.49e-05	0.000952	CbGeAlD
Sunitinib—KIT—lymph node—salivary gland cancer	8.62e-05	0.000865	CbGeAlD
Sunitinib—PDGFRB—lymph node—salivary gland cancer	8.42e-05	0.000845	CbGeAlD
Sunitinib—ABCC4—lymph node—salivary gland cancer	6.7e-05	0.000672	CbGeAlD
Sunitinib—ABCC2—lymph node—salivary gland cancer	6.49e-05	0.000651	CbGeAlD
Sunitinib—ABCB1—epithelium—salivary gland cancer	5.37e-05	0.000539	CbGeAlD
Sunitinib—KCNH2—lymph node—salivary gland cancer	5.32e-05	0.000534	CbGeAlD
Sunitinib—ABCG2—lymph node—salivary gland cancer	4.73e-05	0.000475	CbGeAlD
Sunitinib—ABCB1—lymphoid tissue—salivary gland cancer	4.14e-05	0.000415	CbGeAlD
Sunitinib—ABCB1—lymph node—salivary gland cancer	2.33e-05	0.000234	CbGeAlD
Sunitinib—KIT—Signaling Pathways—CREBBP—salivary gland cancer	1.35e-06	7.37e-06	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—EP300—salivary gland cancer	1.35e-06	7.37e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—EP300—salivary gland cancer	1.35e-06	7.35e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—EP300—salivary gland cancer	1.34e-06	7.3e-06	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—PIK3CA—salivary gland cancer	1.33e-06	7.26e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PHGDH—salivary gland cancer	1.33e-06	7.25e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—PTEN—salivary gland cancer	1.33e-06	7.23e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—CCND1—salivary gland cancer	1.33e-06	7.22e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—CCND1—salivary gland cancer	1.33e-06	7.22e-06	CbGpPWpGaD
Sunitinib—FYN—Adaptive Immune System—HRAS—salivary gland cancer	1.32e-06	7.2e-06	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—PIK3CA—salivary gland cancer	1.32e-06	7.2e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—PTEN—salivary gland cancer	1.32e-06	7.19e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—EP300—salivary gland cancer	1.32e-06	7.17e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—EP300—salivary gland cancer	1.31e-06	7.16e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—PTEN—salivary gland cancer	1.31e-06	7.14e-06	CbGpPWpGaD
Sunitinib—JAK2—Innate Immune System—HRAS—salivary gland cancer	1.31e-06	7.13e-06	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—HRAS—salivary gland cancer	1.31e-06	7.12e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—PTEN—salivary gland cancer	1.31e-06	7.12e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—PTEN—salivary gland cancer	1.31e-06	7.12e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—NOTCH1—salivary gland cancer	1.3e-06	7.11e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—CCND1—salivary gland cancer	1.29e-06	7.04e-06	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—TP53—salivary gland cancer	1.29e-06	7.02e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—CREBBP—salivary gland cancer	1.28e-06	7e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—CREBBP—salivary gland cancer	1.28e-06	6.98e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ST3GAL4—salivary gland cancer	1.28e-06	6.97e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—PTEN—salivary gland cancer	1.28e-06	6.97e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—PTEN—salivary gland cancer	1.28e-06	6.97e-06	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—TP53—salivary gland cancer	1.28e-06	6.97e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—PTEN—salivary gland cancer	1.27e-06	6.95e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—NOTCH1—salivary gland cancer	1.27e-06	6.94e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—EP300—salivary gland cancer	1.27e-06	6.9e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—EP300—salivary gland cancer	1.26e-06	6.85e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—EP300—salivary gland cancer	1.25e-06	6.81e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—PTEN—salivary gland cancer	1.25e-06	6.79e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—EP300—salivary gland cancer	1.25e-06	6.79e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—EP300—salivary gland cancer	1.25e-06	6.79e-06	CbGpPWpGaD
Sunitinib—ABCB1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	1.24e-06	6.75e-06	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—HRAS—salivary gland cancer	1.23e-06	6.71e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—PTEN—salivary gland cancer	1.23e-06	6.69e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—NOTCH1—salivary gland cancer	1.23e-06	6.69e-06	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—HRAS—salivary gland cancer	1.22e-06	6.66e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—PTEN—salivary gland cancer	1.22e-06	6.66e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—NOTCH1—salivary gland cancer	1.22e-06	6.65e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—EP300—salivary gland cancer	1.22e-06	6.65e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—EP300—salivary gland cancer	1.22e-06	6.65e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—EP300—salivary gland cancer	1.22e-06	6.62e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—PTEN—salivary gland cancer	1.21e-06	6.57e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—PIK3CA—salivary gland cancer	1.19e-06	6.48e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—EP300—salivary gland cancer	1.19e-06	6.48e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—CREBBP—salivary gland cancer	1.18e-06	6.44e-06	CbGpPWpGaD
Sunitinib—YES1—Immune System—PIK3CA—salivary gland cancer	1.18e-06	6.43e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—PTEN—salivary gland cancer	1.18e-06	6.41e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—EP300—salivary gland cancer	1.17e-06	6.38e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—PTEN—salivary gland cancer	1.17e-06	6.36e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—NOTCH1—salivary gland cancer	1.17e-06	6.35e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—EP300—salivary gland cancer	1.17e-06	6.35e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—AQP1—salivary gland cancer	1.16e-06	6.33e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—CREBBP—salivary gland cancer	1.15e-06	6.29e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—EP300—salivary gland cancer	1.15e-06	6.27e-06	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—PIK3CA—salivary gland cancer	1.14e-06	6.22e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—PTEN—salivary gland cancer	1.13e-06	6.18e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—PTEN—salivary gland cancer	1.13e-06	6.15e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—EP300—salivary gland cancer	1.12e-06	6.12e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—CCND1—salivary gland cancer	1.12e-06	6.11e-06	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—PIK3CA—salivary gland cancer	1.12e-06	6.1e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—EP300—salivary gland cancer	1.11e-06	6.07e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CREBBP—salivary gland cancer	1.11e-06	6.06e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CREBBP—salivary gland cancer	1.11e-06	6.03e-06	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—TP53—salivary gland cancer	1.1e-06	6.02e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—HRAS—salivary gland cancer	1.1e-06	6e-06	CbGpPWpGaD
Sunitinib—YES1—Immune System—HRAS—salivary gland cancer	1.09e-06	5.95e-06	CbGpPWpGaD
Sunitinib—TYK2—Immune System—PIK3CA—salivary gland cancer	1.09e-06	5.92e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—PTEN—salivary gland cancer	1.08e-06	5.9e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—EP300—salivary gland cancer	1.08e-06	5.89e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—PTEN—salivary gland cancer	1.08e-06	5.88e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—EP300—salivary gland cancer	1.08e-06	5.86e-06	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—PIK3CA—salivary gland cancer	1.07e-06	5.85e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—CREBBP—salivary gland cancer	1.07e-06	5.85e-06	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—PIK3CA—salivary gland cancer	1.07e-06	5.83e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—CREBBP—salivary gland cancer	1.06e-06	5.79e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—CCND1—salivary gland cancer	1.06e-06	5.79e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—PIK3CA—salivary gland cancer	1.06e-06	5.78e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CREBBP—salivary gland cancer	1.06e-06	5.76e-06	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—HRAS—salivary gland cancer	1.06e-06	5.75e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—PIK3CA—salivary gland cancer	1.05e-06	5.75e-06	CbGpPWpGaD
Sunitinib—KIT—Immune System—PIK3CA—salivary gland cancer	1.05e-06	5.75e-06	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—HRAS—salivary gland cancer	1.04e-06	5.65e-06	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—TP53—salivary gland cancer	1.04e-06	5.64e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—CCND1—salivary gland cancer	1.03e-06	5.62e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—EP300—salivary gland cancer	1.03e-06	5.62e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—EP300—salivary gland cancer	1.03e-06	5.6e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—TP53—salivary gland cancer	1.03e-06	5.59e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—PTEN—salivary gland cancer	1.03e-06	5.59e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—CCND1—salivary gland cancer	1.02e-06	5.56e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—PIK3CA—salivary gland cancer	1.01e-06	5.5e-06	CbGpPWpGaD
Sunitinib—TYK2—Immune System—HRAS—salivary gland cancer	1.01e-06	5.48e-06	CbGpPWpGaD
Sunitinib—TYK2—Disease—PIK3CA—salivary gland cancer	1e-06	5.47e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—CCND1—salivary gland cancer	1e-06	5.46e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—CCND1—salivary gland cancer	1e-06	5.46e-06	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—PIK3CA—salivary gland cancer	1e-06	5.45e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—PIK3CA—salivary gland cancer	9.98e-07	5.44e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—PTEN—salivary gland cancer	9.96e-07	5.43e-06	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—HRAS—salivary gland cancer	9.93e-07	5.41e-06	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—PIK3CA—salivary gland cancer	9.93e-07	5.41e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—PIK3CA—salivary gland cancer	9.91e-07	5.4e-06	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—HRAS—salivary gland cancer	9.91e-07	5.4e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—PTEN—salivary gland cancer	9.84e-07	5.36e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—HRAS—salivary gland cancer	9.82e-07	5.35e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—EP300—salivary gland cancer	9.79e-07	5.33e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—HRAS—salivary gland cancer	9.76e-07	5.32e-06	CbGpPWpGaD
Sunitinib—KIT—Immune System—HRAS—salivary gland cancer	9.76e-07	5.32e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—PIK3CA—salivary gland cancer	9.74e-07	5.3e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—PIK3CA—salivary gland cancer	9.72e-07	5.3e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—PTEN—salivary gland cancer	9.67e-07	5.27e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—PTEN—salivary gland cancer	9.67e-07	5.27e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—CCND1—salivary gland cancer	9.5e-07	5.18e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—EP300—salivary gland cancer	9.5e-07	5.18e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—CCND1—salivary gland cancer	9.48e-07	5.16e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—PIK3CA—salivary gland cancer	9.44e-07	5.14e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—TP53—salivary gland cancer	9.41e-07	5.13e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—EP300—salivary gland cancer	9.39e-07	5.11e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—PIK3CA—salivary gland cancer	9.37e-07	5.1e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—HRAS—salivary gland cancer	9.33e-07	5.08e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—PIK3CA—salivary gland cancer	9.31e-07	5.07e-06	CbGpPWpGaD
Sunitinib—TYK2—Disease—HRAS—salivary gland cancer	9.29e-07	5.06e-06	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—HRAS—salivary gland cancer	9.26e-07	5.05e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—PIK3CA—salivary gland cancer	9.24e-07	5.03e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—HRAS—salivary gland cancer	9.24e-07	5.03e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—NUP62—salivary gland cancer	9.22e-07	5.02e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—EP300—salivary gland cancer	9.22e-07	5.02e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—EP300—salivary gland cancer	9.22e-07	5.02e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—PIK3CA—salivary gland cancer	9.22e-07	5.02e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—PIK3CA—salivary gland cancer	9.22e-07	5.02e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—PTEN—salivary gland cancer	9.17e-07	5e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—HRAS—salivary gland cancer	9.17e-07	5e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—PTEN—salivary gland cancer	9.15e-07	4.98e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—VCAN—salivary gland cancer	9.15e-07	4.98e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—TP53—salivary gland cancer	9.06e-07	4.94e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—PIK3CA—salivary gland cancer	9.02e-07	4.92e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—PIK3CA—salivary gland cancer	9.02e-07	4.92e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—PIK3CA—salivary gland cancer	9.02e-07	4.91e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—HRAS—salivary gland cancer	9.01e-07	4.91e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—TP53—salivary gland cancer	9e-07	4.9e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—HRAS—salivary gland cancer	9e-07	4.9e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—PIK3CA—salivary gland cancer	8.99e-07	4.9e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—PIK3CA—salivary gland cancer	8.79e-07	4.79e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—CCND1—salivary gland cancer	8.75e-07	4.77e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—EP300—salivary gland cancer	8.75e-07	4.77e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—HRAS—salivary gland cancer	8.73e-07	4.76e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—TP53—salivary gland cancer	8.73e-07	4.76e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—TP53—salivary gland cancer	8.73e-07	4.76e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—EP300—salivary gland cancer	8.73e-07	4.75e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—PIK3CA—salivary gland cancer	8.67e-07	4.72e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—HRAS—salivary gland cancer	8.67e-07	4.72e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—PIK3CA—salivary gland cancer	8.62e-07	4.7e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—HRAS—salivary gland cancer	8.61e-07	4.69e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—HRAS—salivary gland cancer	8.55e-07	4.66e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—CCND1—salivary gland cancer	8.54e-07	4.65e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—HRAS—salivary gland cancer	8.53e-07	4.65e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—HRAS—salivary gland cancer	8.53e-07	4.65e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—PIK3CA—salivary gland cancer	8.51e-07	4.64e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—TP53—salivary gland cancer	8.51e-07	4.63e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—PTEN—salivary gland cancer	8.45e-07	4.6e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—HRAS—salivary gland cancer	8.35e-07	4.55e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—HRAS—salivary gland cancer	8.35e-07	4.55e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—HRAS—salivary gland cancer	8.34e-07	4.55e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—HRAS—salivary gland cancer	8.32e-07	4.53e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—PIK3CA—salivary gland cancer	8.3e-07	4.52e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—PTEN—salivary gland cancer	8.24e-07	4.49e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—PIK3CA—salivary gland cancer	8.24e-07	4.49e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CCND1—salivary gland cancer	8.23e-07	4.48e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CCND1—salivary gland cancer	8.19e-07	4.46e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—HRAS—salivary gland cancer	8.14e-07	4.43e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—EP300—salivary gland cancer	8.05e-07	4.39e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—HRAS—salivary gland cancer	8.02e-07	4.37e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—PIK3CA—salivary gland cancer	8e-07	4.36e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—HRAS—salivary gland cancer	7.98e-07	4.35e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—PIK3CA—salivary gland cancer	7.96e-07	4.34e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—PTEN—salivary gland cancer	7.94e-07	4.33e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—PTEN—salivary gland cancer	7.9e-07	4.31e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—HRAS—salivary gland cancer	7.87e-07	4.29e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—EP300—salivary gland cancer	7.86e-07	4.28e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CCND1—salivary gland cancer	7.82e-07	4.26e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—CREBBP—salivary gland cancer	7.69e-07	4.19e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—HRAS—salivary gland cancer	7.68e-07	4.19e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PTEN—salivary gland cancer	7.66e-07	4.18e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—PIK3CA—salivary gland cancer	7.63e-07	4.16e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—HRAS—salivary gland cancer	7.62e-07	4.15e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—PIK3CA—salivary gland cancer	7.61e-07	4.15e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PTEN—salivary gland cancer	7.6e-07	4.14e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—EP300—salivary gland cancer	7.58e-07	4.13e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—PTEN—salivary gland cancer	7.55e-07	4.11e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—EP300—salivary gland cancer	7.54e-07	4.11e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—HRAS—salivary gland cancer	7.4e-07	4.03e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—TP53—salivary gland cancer	7.39e-07	4.02e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—HRAS—salivary gland cancer	7.37e-07	4.01e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—EP300—salivary gland cancer	7.31e-07	3.98e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—EP300—salivary gland cancer	7.24e-07	3.95e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—PIK3CA—salivary gland cancer	7.24e-07	3.95e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—EP300—salivary gland cancer	7.2e-07	3.92e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—HRAS—salivary gland cancer	7.06e-07	3.85e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—HRAS—salivary gland cancer	7.04e-07	3.84e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—PIK3CA—salivary gland cancer	7.03e-07	3.83e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—TP53—salivary gland cancer	7.01e-07	3.82e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—PIK3CA—salivary gland cancer	6.94e-07	3.78e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—PIK3CA—salivary gland cancer	6.82e-07	3.71e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—PIK3CA—salivary gland cancer	6.82e-07	3.71e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—TP53—salivary gland cancer	6.8e-07	3.71e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—TP53—salivary gland cancer	6.72e-07	3.66e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—HRAS—salivary gland cancer	6.7e-07	3.65e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—TP53—salivary gland cancer	6.6e-07	3.59e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—TP53—salivary gland cancer	6.6e-07	3.59e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—HRAS—salivary gland cancer	6.5e-07	3.54e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—PIK3CA—salivary gland cancer	6.47e-07	3.53e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—PIK3CA—salivary gland cancer	6.45e-07	3.52e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—HRAS—salivary gland cancer	6.42e-07	3.5e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—HRAS—salivary gland cancer	6.31e-07	3.44e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—HRAS—salivary gland cancer	6.31e-07	3.44e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—TP53—salivary gland cancer	6.26e-07	3.41e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—TP53—salivary gland cancer	6.24e-07	3.4e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—HRAS—salivary gland cancer	5.99e-07	3.26e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—HRAS—salivary gland cancer	5.97e-07	3.25e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—PIK3CA—salivary gland cancer	5.96e-07	3.25e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—PIK3CA—salivary gland cancer	5.81e-07	3.17e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CREBBP—salivary gland cancer	5.8e-07	3.16e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—TP53—salivary gland cancer	5.76e-07	3.14e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—TP53—salivary gland cancer	5.63e-07	3.06e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—PIK3CA—salivary gland cancer	5.6e-07	3.05e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—PIK3CA—salivary gland cancer	5.57e-07	3.04e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—HRAS—salivary gland cancer	5.51e-07	3e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PTEN—salivary gland cancer	5.49e-07	2.99e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—TP53—salivary gland cancer	5.42e-07	2.95e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PIK3CA—salivary gland cancer	5.41e-07	2.95e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—TP53—salivary gland cancer	5.39e-07	2.94e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—HRAS—salivary gland cancer	5.38e-07	2.93e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PIK3CA—salivary gland cancer	5.36e-07	2.92e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—PIK3CA—salivary gland cancer	5.33e-07	2.9e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—EP300—salivary gland cancer	5.24e-07	2.85e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—HRAS—salivary gland cancer	5.19e-07	2.83e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—HRAS—salivary gland cancer	5.16e-07	2.81e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—TP53—salivary gland cancer	5.15e-07	2.81e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—HRAS—salivary gland cancer	4.93e-07	2.69e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PTEN—salivary gland cancer	4.14e-07	2.26e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—EP300—salivary gland cancer	3.95e-07	2.15e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PIK3CA—salivary gland cancer	3.87e-07	2.11e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CREBBP—salivary gland cancer	3.57e-07	1.95e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PIK3CA—salivary gland cancer	2.92e-07	1.59e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PTEN—salivary gland cancer	2.55e-07	1.39e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—EP300—salivary gland cancer	2.43e-07	1.33e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PIK3CA—salivary gland cancer	1.8e-07	9.81e-07	CbGpPWpGaD
